ALK ABELL贸
ALK is a global research-driven pharmaceutical company that focuses on prevention, diagnosis and treatment of allergies. Since 1923 ALK has been working to improve the quality of life for allergy patients by developing drugs that target the cause of allergy. ALK is the world leader in allergy immunotherapy - a unique treatment of the cause of allergies. The treatment induces a protective immune response that provides a sustained reduction of allergy symptoms and reduces the risk of developing... asthma. ALK provides allergy immunotherapy products as injections, sublingual drops and sublingual tablets, which is the newest, best documented and most convenient treatment for patients. The portfolio of products also includes an adrenaline used to treat severe allergic reactions (anaphylactic shock). ALK invests annually approx. 20% of revenue in research that aims to develop new, evidence-based allergy immunotherapy. Research and development pipeline includes sublingual allergy immunoterapy tablets against ragweed, house dust mite and tree pollen allergy. ALK has signed partnership agreements with Merck and Torii Pharmaceutical, concerning the development, registration and commercialisation of tablets in Northern America and Japan. ALK has approx. 1,800 employees with subsidiaries, production facilities and distributors worldwide. The company headquarters is in Denmark and is listed on NASDAQ OMX Copenhagen (OMX: ALK B). In 2013 the turnover was more than DKK 2.2 billion (EURm 300).
ALK ABELL贸
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1923-01-01
Address:
H酶rsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.alk-abello.com
Total Employee:
1001+
Status:
Active
Contact:
45 45 74 75 76
Technology used in webpage:
SPF SSL By Default Apache IPv6 IIS 10 Microsoft ASP.NET 4.0 Microsoft Azure Barracuda Networks Akamai Hosted
Similar Organizations
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Gendiag
gen to A monster is a biotechnological research and development company, founded in 2006 to facilitate personalized medicine.
Labmaster
Labmaster delivers innovative diagnostics tools for applications in routine clinical diagnostics and research.
Lofarma S.p.A.
Lofarma is the leading pharmaceutical company in the diagnosis and treatment of allergic respiratory diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company聽focused on the聽prevention and treatment of gastrointestinal disorders.
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2014-03-05 | Bio鈥怣edical Services | Bio鈥怣edical Services acquired by ALK Abell贸 | N/A |
2005-05-27 | Allerbio | Allerbio acquired by ALK Abell贸 | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2011-01-05 | DBV Technologies | ALK Abell贸 investment in Series C - DBV Technologies | 25.5 M USD |
2009-01-22 | DBV Technologies | ALK Abell贸 investment in Series B - DBV Technologies | 6 M EUR |
Newest Events participated
Official Site Inspections
http://www.alk-abello.com
- Host name: redirect.portsit.se
- IP address: 193.14.90.203
- Location: Sweden
- Latitude: 59.3247
- Longitude: 18.056
- Timezone: Europe/Stockholm